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The spine is the most common site for skeletal metastasis in patients with
malignancy.
1-3 Approximately 30-70% of patients with an advanced malignancy
have an evidence of spinal metastasis.
4-6 Surgical treatment of spinal metastases,
particularly when the tumor extends beyond the anatomical barrier of the spine,
remains a source of debate.
4,7,8 Many clinicians consider radiation therapy as the
initial choice of treatment for spinal metastases of malignant tumors;
9,10 however,
surgical intervention for spinal metastatic tumors is still indicated for patients with
intractable pain that is unresponsive to conservative care, signs of neurological
compromise, spinal instability observed on radiological evaluation, and for
patients who do not respond to radiation therapy and/or chemotherapy.
2 Moreover,
total resection of complicated metastatic spinal tumors is possible using recently
developed surgical techniques, such as total en bloc spodylectomy.
8,11
The goals of surgical intervention are to prolong the survival period and improve
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the quality of life of patients, with minimal surgical
complications. Therefore, prognostic factors for spinal
metastasis need to be well established in order to reach an
appropriate decision on treatment modalities. In general,
the survival rate of malignant tumors is largely dependent
on the histology of the primary tumor and on the presence
of visceral or bone metastases, which include spine
metastasis.
12,13 According to preoperative scoring systems,
which serve to determine the surgical strategy for spinal
metastases, rapidly growing primary tumors, visceral
metastases, and multiple bone metastases are poor
preoperative prognostic factors.
12,13
Tomita, et al.
11,14 devised a surgical classification of spinal
tumors in which intracompartmental, extracompartmental,
and multiple lesions are classified according to tumor
location inside or outside the vertebral anatomical barrier.
Extracompartmental lesions include metastatic tumors that
grow into the spinal canal (type 4), extend outside the
vertebral body (type 5), and finally spread to the adjacent
vertebra(e) (type 6). Multiple-skip spinal metastases re-
present type 7. In terms of surgical prognostic factors,
excellent results have been reported for aggressive total en
bloc spondylectomy of intracompartmental tumors;
8,11,13
however, few prognostic factors associated with surgical
resection are known for spinal metastases that extend
beyond the anatomical barriers and compartment (Tomita’s
classification ≥type 4).
The aim of this study was to evaluate whether the extent
of tumor resection in different primary tumors has an
effect on the survival rate and neurological outcomes in
patients with advanced spinal metastasis (Tomita’s classi-
fication ≥type 4).
Patients
This study was based on a retrospective review of 87
patients (male-to-female ratio, 50 : 37) who had advanced
spinal metastasis that extended beyond the anatomical
barrier (Tomita’s classification ≥ type 4) and who under-
went surgical intervention in our institution between August
1997 and February 2008. The mean age of the patients was
57 years (range, 27-76). The average clinical and radiolo-
gical follow-up period was 24.5 months (range, 1-75
months) (Table 1).
Surgery was performed in patients who had six months
or more of life expectancy, as predicted by oncologists,
and who had progressive neurological deficit before,
during, or after radiation therapy, and who had intractable
pain unresponsive to conservative treatment, and/or spinal
instability or vertebral collapse. Some patients were under
radio- and/or chemotherapy. If the neurological status or
spinal stability of the patient worsened during adjuvant
therapy, we considered surgical tumor resection and
stabilization of the spinal column. The adjuvant therapy
MATERIALS AND METHODS
Table 1.Characteristics of Patients with Spinal Metastases
Group 1 Group 2 Total
No. of patients 36 51 87
Male-to-female ratio 14 : 22 36 : 15 50 : 37
Mean age (yrs) 54.0 (12 - 75) 55.7 (16 - 79) 55 (12 - 79)
Mean follow-up (months) 28.6 (2 - 75) 9.1 (1 - 50) 17.6 (1 - 75)
Spinal location
Cervical 4 11 15
Thoracic 24 29 53
Lumbar 7 11 18
Sacrum 1 0 1
Tomita’s classification
Type 4 9 7 16
Type 5 9 8 17
Type 6 7 16 23
Type 7 11 20 31
Extent of tumor resection
Gross total (G1GT, 15) (G2GT, 13) 28
Subtotal (G1ST, 21) (G2ST, 38) 59
G1GT, gross total resection in group 1; G1ST, subtotal resection in group 1; G2GT, gross total resection in group 2; G2ST, subtotal resection 
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was resumed after confirmation of the complete healing of
the surgical wound. Patients who were followed-up for
more than one year after the operation and who had a
definite primary malignancy lesion were included in this
study. Patients who died within one year of the operation
were also included.
For tumor grading using Tomita’s classification, we
used bone scintigraphy, preoperative magnetic resonance
imaging (MRI) of the entire spine, and computed tomo-
graphy (CT) of the chest, abdomen, and brain. Exclusion
criteria for the study were as follows: spinal metastasis
with unknown primary origin, a follow-up period shorter
than one year, tumor grade less than type 4 (Tomita’s
classification), and patients who underwent only biopsy or
vertebroplasty.
Grouping of the patients
The patients were divided into two groups according to the
characteristic of the primary malignant tumor:
11,15-18 group 1
included tumors known to respond to adjuvant chemo-
therapy, radiotherapy, or hormonal therapy (thyroid cancer,
breast cancer, prostate cancer, and hematopoietic malig-
nancy); group 2 comprised tumors known not to respond
well to adjuvant therapy (lung cancer, hepatocellular carci-
noma, pancreas cancer, renal cell cancer, sarcoma, and
gastrointestinal cancer).
Groups 1 and 2 were further divided into two subgroups
according to the extent of tumor resection (gross total vs.
subtotal), which was analyzed using radiological studies
and operation records. Gross total resection meant that no
tumor mass remained attached to the surrounding normal
tissues via thorough debulking and removal of the marginal
barriers or total en bloc spondylectomy via a posterior-
only or anterior-posterior combined approach. For subtotal
resection, laminectomy or internal decompression with/
without instrumentation was performed. Patients with
remaining tumor mass at the operated site or at other bone
sites (including vertebrae) were classified in the subtotal
resection group. As a result of patient grouping according
to extent of surgical resection, four subgroups were obtained:
group 1, gross total resection (G1GT); group 1, subtotal
resection (G1ST); group 2, gross total resection (G2GT);
and group 2, subtotal resection (G2ST) (Table 1 and 2).
Evaluation of survival rates and neurological status
We analyzed survival periods, grade of metastatic spinal
tumor (using Tomita’s classification), primary tumor entities,
extent of tumor resection, and neurological outcomes. The
survival period after operation was calculated to the last
date of the follow-up in the patients who were still alive, or
to the date of expiration. Statistical analysis of the survival
period was performed using the Kaplan-Meier method and
the log-rank test was used for statistical comparisons.
Significance was achieved if the probability was lower
than 5% (p< 0.05).
The neurological outcome was graded before and after
surgery using Frankel’s grade system.
19 We converted
Frankel’s grades A, B, C, D, and E into Frankel’s points 1,
2, 3, 4, and 5. To compare neurological improvement
among the four subgroups, the sum of Frankel’s points in
each subgroup was expressed as a percentage of the sum
of full points: 100× (patients’ Frankel points)/5×
(number of patients). The neurological status of each
subgroup was estimated and compared at the preoperative
stage, at one month after surgery, and at last follow-up.
Statistical analysis of the neurological outcome was
performed using the paired t test. Significance was achie-
ved if the probability was lower than 5% (p< 0.05).
Characteristics of patients in groups 1 and 2
Patient characteristics are listed in Table 1. Groups 1 and 2
comprised 36 and 51 patients, respectively. The most
frequent site of spinal metastasis was the thoracic spine
(67% of patients in group 1 and 57% of patients in group
2), followed by the lumbar and cervical spine.
Among the 87 patients, 56 individuals had an isolated
spinal metastasis (Tomita classification types 4, 5, or 6),
whereas 31 patients had multiple metastases (type 7). In
terms of multiple bone metastases, 39% of patients in
RESULTS
Table 2. Tomita’s Classification according to the Extent of Tumor Resection
Tomita’s classification G1GT G1ST G2GT G2ST
Gross total 
resection (%)
Type  4 8 1 5 2 81
Type  5 5 4 3 5 47
Type  6 2 5 5 11 30
Type  7 0 11 0 20 0
Total 15 21 13 38 32
G1GT, gross total resection in group 1; G1ST, subtotal resection in group 1; G2GT, gross total resection in group 2; G2ST, subtotal resection 
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group 2 were type 7 and 31% of patients in group 1 were
type 7. 
Gross total resection of tumors was achieved in 28
patients (32%). Gross total resection of spinal tumors was
performed more frequently in group 1 than in group 2
(42% vs. 25%). In terms of Tomita’s classification, the ratio
of gross total resection was 81, 47, and 30% for Tomita’s
type 4, 5, and 6, respectively (Table 2).
Tumor origin and pathological diagnosis
Among the 36 patients included in group 1, the most com-
mon origin of primary tumors was the bone marrow (12
cases) and breast tissues (12 cases), followed by the thyroid
(9 cases) and the prostate (3 cases). Among the 51 patients
included in group 2, the lung (12 cases) was the most com-
mon primary tumor site, followed by the liver (8 cases)
and the kidney (7 cases) (Table 3). Thyroid cancer cases
showed the highest one-year survival rate, followed by
cancers of the breast and of the bone marrow. In contrast,
lung cancer patients had the worst one-year survival rate
(17%), followed by liver, colon, and kidney cancers. The
most common overall pathologic cell types were adeno-
carcinoma (23 cases), followed by ductal cell carcinoma
(12 cases), plasmacytoma (8 cases), hepatocellular carci-
noma (8 cases), and squamous cell carcinoma (7 cases).
Survival rates
Patients in group 1 had a better survival rate than patients
in group 2 (p = 0.009) (Fig. 1). The mean survival period
was 28.6 months (range, 2-75) for group 1 and 9.1 months
(range, 1-50) for group 2. In group 1, 5 out of 36 patients
Table 3. Origin of Primary Tumors
Origin of tumor No. of cases
1-year 
survival rate (%)
Group 1
Bone marrow 12 75
Breast 12 83
Thyroid 9 100
Prostate 3 N/A
Group 2
Lung 12 17
Liver 8 25
Kidney 7 43
Colon 6 30
Rectal 3 N/A
Pancreas 2 N/A
Stomach 2 N/A
Cervix 2 N/A
Nasoparhynx 2 N/A
Uterus 1 N/A
Ovary 1 N/A
Parotid gland 1 N/A
Ethmoid sinus 1 N/A
Skin 1 N/A
Orbit 1 N/A
Chondrosarcoma 1 N/A
Total 87
N/A indicates nonavailable survival rate because of the small sample size.
S
u
r
v
i
v
a
l
 
r
a
t
e
Survival period (months)
1
2
Tumor group 1.0
0.8
0.6
0.4
0.2
0.0
0 20 40 60 80
Fig. 1. Comparison of the postoperative survival rate between groups 1 and 2.
Kaplan-Meier survival curves of patients with spinal metastases in group 1
(breast cancer, thyroid cancer, hematopoietic malignancy, and prostate cancer)
and group 2 (lung cancer, hepatocellular cancer, renal cell cancer, colon
cancer, pancreas cancer, rectal cancer, etc) showed a significantly higher
survival rate for patients in group 1 (p< 0.01).
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Fig. 2. Comparison of the postoperative survival rate between gross total
resection and subtotal resection subgroups of group 1. Kaplan-Meier survival
curves revealed a significantly higher survival rate for patients who received
gross total resection of tumor when compared with subtotal resection (p =
0.049).had died within one year after the operation (one-year
survival rate = 86.2%); however, 28 patients were alive at
the last follow-up. In group 2, 34 out of 51 patients died
within one year after the operation (one-year survival rate
= 33.3%) and only 13 patients were alive at the last follow-
up. The average follow-up period for patients in groups 1
and 2 who died was 27.1 and 7.8 months, respectively.
The analysis of the survival rate according to the extent
of tumor resection revealed that one patient expired six
months after the operation and the remaining 14 patients in
the G1GT subgroup were alive at the last follow-up. In
contrast, 7 out of 21 patients in the G1ST subgroup, expired
and 14 patients were alive at the last follow-up. Therefore,
the G1GT subgroup showed a significantly better survival
rate (p = 0.049) when compared with the G1ST subgroup
(Figs. 2 and 3). The mean survival period was 36.5 months
(range, 2-75) for the G1GT subgroup and 28.3 months
(range, 1-60) for the G1ST subgroup. In group 2, the
extent of tumor resection (G2GT vs. G2ST) did not affect
the survival rate of patients (p= 0.115) (Fig. 4).
Forty-six patients died before the last follow-up: 8
patients (22.2%) in group 1 and 38 patients (74.5%) in
group 2. The most common causes of death were major
organ metastasis and failure, especially pulmonary and
hepatic failure. Six patients expired because of septic
shock and one patient expired because of intracerebral
hemorrhage. There were no significant differences in the
cause of death between groups 1 and 2.
Neurological improvement and local recurrence after
gross total resection
In the G1GT subgroup, preoperative neurological status
was 89% of full points, which significantly improved to
98% one month after the operation and to 99% at the time
of last follow-up (p = 0.008). There was no significant dif-
ference in neurological status between one month after the
operation and the last follow-up. In the G1ST subgroup,
the neurological status at one month after the operation
improved slightly from 76 to 80% (p= 0.961), but worsened
to 76% at the time of the last follow-up. In the G2GT
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Fig. 3. Illustration of a case of metastatic thyroid cancer involving the T9 vertebra.
A 53-year-old female patient, who had severe back pain and paraparesis,
underwent gross total resection of the tumor using an anterior and posterior
combined approach and instrumentation. (A) T1-weighted MR axial image
shows metastatic spinal tumor extended to the right paraspinal space (Tomita’s
classification type 5). (B) Preoperative bone scintigraphy image shows single
metastatic lesion on T9. (C) Postoperative X-ray image shows posterior pedicle
screw fixation after total T9 spondylectomy. The mesh cage was filled with
polymethylmethacrylate. (D) Bone scintigraphy image taken 39 months after
surgery shows resected T9 vertebra and ribs without recurrent lesion.
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Fig. 4. Comparison of postoperative survival rate between gross total resection
and subtotal resection subgroups of group 2. Kaplan-Meier survival curves
show absence of statistical differences between patients who received gross
total and subtotal resection of tumor (p= 0.115).subgroup, the neurological status improved significantly
from 89% preoperatively to 96% one month after the opera-
tion (p = 0.019), but worsened to 93% at the last follow-up;
however, there was a significant improvement in neurolo-
gical status between the preoperative time point and the
time of last follow-up (p = 0.041). In the G2ST subgroup,
the neurological status improved from 81% to 85% (p =
0.048) at one month after the operation, but worsened to
78% at the time of last follow-up, which was even worse
than the preoperative neurological status (Fig. 5).
Three of the 15 patients in the G1GT subgroup showed
a remote recurrence of spinal metastasis, which was remov-
ed by secondary operation. There was no local recurrence
in the G1GT subgroup at the last follow-up. Four of the 13
patients in the G2GT subgroup had a local recurrence of
spinal tumor and progressive worsening of neurological
status.
In the 1980s, patients with spinal metastases were consi-
dered to be in the terminal stage of disease, as about half of
them died within six months of spinal surgery.
20 Recently,
however, the survival rate of malignant spinal metastases
has rapidly improved because of early detection of metas-
tases and multimodality treatment, which includes the
development of surgical techniques. Life expectancy, the
general condition of a patient, the characteristics of the
primary tumor, and the resectability of metastatic tumor
masses should be considered in the surgical treatment of
advanced metastatic spinal tumors. The prognostic para-
meters suggested for metastatic spine tumors include the
general condition of the patient, number of spinal and ex-
traspinal metastases, primary site of the cancer, visceral
metastasis, and severity of spinal cord palsy.
11-13,21 Among
them, the presence of spinal tumor metastasis and spinal
cord palsy are controllable surgical factors, if efficient total
resection of the tumor mass can be achieved.
Our present results showed that the survival rate in cases
with advanced spinal metastasis was affected largely by
the pathological characteristics of the primary tumors.
Before and/or after spinal tumor surgery, the primary
tumor was managed medically or surgically by each
responsible department. Some patients died because of
major organ metastasis, even though there was no recur-
rence at the site of spinal surgery. It seems that 100% of
thyroid cancer patients survived at the last follow-up
because curative tumor resection was possible in most
cases. We think that complete control of the primary tumor
is as important for long-term survival as the pathological
type of the tumor. Previous studies addressing the survi-
vability of patients showed a favorable prognosis for cases
with spinal metastases,
11,13,22,23 myeloma, breast, thyroid,
and prostate cancers, while patients with cancers of the
lung, liver, and gastrointestinal tract had poor prognosis.
Visceral metastases at the time of the first surgical treat-
ment of a bony metastasis are significantly correlated with
survival time,
24,25 and, as shown in this study, major organ
failure is the most common cause of death. Cancers of the
lung and liver, which were classified as tumors not res-
ponding well to adjuvant therapy (group 2) in this study,
are the most common metastatic spinal tumors, and the
primary sites themselves represent the beginning of major
visceral organ failure. In renal cell cancer, the prognosis
ranges from favorable to poor.
13,22,26 In the case of intracom-
partmental metastasis, a long survival time would be ex-
pected after total en bloc spondylectomy.
11,13 As all the cases
in our series were extracompartmental spinal metastasis,
renal cell cancer (Tomita’s classification ≥ type 4) was
classified as group 2. Nevertheless, the renal cell cancer
cases analyzed here exhibited a better survival rate when
compared with lung, liver, or colon cancer cases. Our results
seem to indicate that the characteristics and controllability
of the primary tumor are of vital importance in the decision-
making process regarding the goal of the surgery (i.e., gross
total removal or palliative decompression). Overtreatment
of the patients by aggressive resection to obtain minimal
surgical benefits must be avoided; however, aggressive
total tumor resection should be a surgical goal for patients
who have spinal metastasis from a favorable primary
tumor, even if the metastasis extends beyond the vertebral
compartment.
Young Min Kwon, et al.
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Fig. 5. Neurological grade assessed by conversion of Frankel’s grade system to
a point system. The neurological status of the G1GT and G2GT subgroups was
significantly improved one month after surgery and at the last follow-up. In
contrast, the G1ST and G2ST subgroups improved shortly after surgery but
worsened at the time of last follow-up; in particular, the neurological status of
the G2ST subgroup became even worse than at the preoperative stage.
*Significantly improved neurological status when compared with the
preoperative stage (p< 0.05). 
�Significantly worsened neurological status when
compared with the preoperative stage (p< 0.05).Although cases of spinal metastasis from low-grade
malignant tumors show a higher survival rate after surgery,
surgeons may be conflicted as to whether total removal or
subtotal resection of the tumor should be performed. As
surgery-related complications, which include wound infec-
tion, excessive blood loss, neurological deterioration, and
death, can occur,
2 aggressive surgical intervention remains
debatable. Because the tumor mass extended beyond the
barriers in our series, it was difficult to remove the whole
mass en bloc and had to be removed frequently in multiple
pieces. During the initial periods of this study, subtotal
resection was more frequent than gross total resection. In
the G1GT subgroup, total en bloc resection was possible
only in 5 of 15 patients (33.3%). In the remaining 10 pati-
ents (66.7%), the tumor mass was removed by dividing it
into several pieces or by debulking the main mass followed
by thorough marginal resection, because of the large tumor
size and irregular margin of invasion. In the group 1 tumors,
though the cases of total en bloc spondylectomy and
thorough debulking with marginal resection were mixed in
the G1GT subgroup, the fact that gross total removal of
metastatic tumors yielded a higher survival rate and better
neurological outcomes when compared with subtotal
removal seems to be meaningful. Considering the higher
survival rate without local recurrence after surgery in the
G1GT subgroup when compared with the G1ST subgroup,
total resection should be the goal of surgery for group 1
tumors. Tomita, et al.
13 reported similar results: 28 patients
treated with wide or wide-marginal excision lived longer
than 13 patients treated with intralesional excision-the
mean survival period was 38.2 vs. 21.5 months, respectively;
however, in their series, some fast- and slow-growing
tumors were mixed in each group of surgical excision and
the extent of tumor invasion (intracompartmental vs. extra-
compartmental) was not clearly differentiated. For gross
total resection, we used the surgical techniques of posterior
or anterior-posterior combined approach. Sometimes we
needed to perform en bloc resection of the ribs attached to
the tumor mass followed by reconstruction of the chest wall
(Fig. 3). Collaborations with other surgical departments
and/or preoperative angiography with selective emboliza-
tion were mandatory considerations to achieve successful
surgeries.
The analysis of the survival rate of group 2 patients
according to the extent of surgical resection revealed that it
was not significantly different between the gross total and
subtotal resection groups. We suggest that minimal surgery
consisting of the decompressive debulking technique
followed by radiotherapy and/or chemotherapy may be the
best choice to treat patients with highly malignant metas-
tatic spinal tumors that extend beyond the anatomical
barrier. Our results do not imply that conservative medical
care or radiation therapy alone is better than surgery in
rapidly growing group 2 spinal metastasis. Despite the low
survival rate of patients with highly malignant spinal metas-
tatic tumors, surgical treatment is still worthy of considera-
tion, as it reduces the intractable pain and leads to neurolo-
gical improvement. In this study, patients showed improved
neurological status shortly after surgery when compared
with the preoperative status. Patchell, et al.
27 reported that
direct decompressive surgical resection followed by radio-
therapy has a superior outcome in improving the neurolo-
gical deficit when compared with radiotherapy alone for
patients with spinal metastatic cancer that compresses the
spinal cord. Our study also showed superior neurological
improvement in the G2GT subgroup compared to that of
the G2ST subgroup. Therefore, gross total resection would
be preferable in selected cases, such as Tomita’s classifica-
tion type 4 or 5. The general condition of the patient (to
endure heavy spinal surgery), less invasiveness into sur-
rounding tissue, and long life expectancy in group 2
tumors are essential factors that should be considered before
deciding for gross total resection.
In summary, our results suggest that gross total resection
of spinal metastatic tumors should be the goal of surgery
when primary tumors respond well to adjuvant therapy.
Even in cases where the tumor mass extends beyond the
anatomical barrier (Tomita’s classification ≥ type 4), gross
total resection of the tumor mass yields better survival
rates and neurological outcomes when compared with
subtotal resection of the tumor. However, in the case of
tumors that do not respond to adjuvant therapy, we suggest
that the surgical intervention of choice should be palliative
decompression of the spinal cord.
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